A new junior research group, headed by Dr. Ignacio Rebollo, officially started operations in January 2026 at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), marking a significant advancement in the burgeoning field of gut-brain…
For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) has demonstrated the causal role of microbially produced secondary bile…
TU Berlin researcher involved in Nature study that shows how the human brain stores content and context separately and combines them together in a targeted manner
“Berlin's vibrant healthtech and AI ecosystem is a crucial component of Bayer's success”
Vaccination as from the 22nd week of pregnancy can save lives worldwide
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant…
Start of the Einstein Center for Early Disease Interception
In its December meeting, the Board of the Einstein Foundation Berlin approved new research projects with a total funding of 13 million euros over the next six years.
Deadline: 13th February 2026
ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.
